Association between Cannabinoid CB1 Receptor Expression and Akt Signalling in Prostate Cancer

22Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.

Abstract

Background:In prostate cancer, tumour expression of cannabinoid CB1 receptors is associated with a poor prognosis. One explanation for this association comes from experiments with transfected astrocytoma cells, where a high CB receptor expression recruits the Akt signalling survival pathway. In the present study, we have investigated the association between CB1 receptor expression and the Akt pathway in a well-characterised prostate cancer tissue microarray.Methodology/Principal Findings:Phosphorylated Akt immunoreactivity (pAkt-IR) scores were available in the database. CB1 receptor immunoreactivity (CB1IR) was rescored from previously published data using the same scale as pAkt-IR. There was a highly significant correlation between CB1IR and pAkt-IR. Further, cases with high expression levels of both biomarkers were much more likely to have a more severe form of the disease at diagnosis than those with low expression levels. The two biomarkers had additive effects, rather than an interaction, upon disease-specific survival.Conclusions/Significance:The present study provides data that is consistent with the hypothesis that at a high CB1 receptor expression, the Akt signalling pathway becomes operative. © 2013 Cipriano et al.

Cite

CITATION STYLE

APA

Cipriano, M., Häggström, J., Hammarsten, P., & Fowler, C. J. (2013). Association between Cannabinoid CB1 Receptor Expression and Akt Signalling in Prostate Cancer. PLoS ONE, 8(6). https://doi.org/10.1371/journal.pone.0065798

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free